FDA Approves OTC Omeprazole in Mini Capsule Form

A mini capsule formulation of omeprazole magnesium delayed-release will be available over-the-counter (OTC) later this year, according to Perrigo.

The Company received final approval to manufacture Omeprazole Magnesium Delayed-Release Mini Capsules, 20mg, allowing for a capsule that is 70% smaller than the currently available tablet version. The product is indicated for the treatment of frequent heartburn. It will be marketed under the retailer’s store brand label.

Omeprazole magnesium delayed-release OTC is a generic version of Prilosec OTC.

Continue Reading

Reference

Perrigo announces US FDA approval for omeprazole magnesium delayed-release mini capsules. News release. May 26, 2022. https://www.prnewswire.com/news-releases/perrigo-announces-us-fda-approval-for-omeprazole- magnesium-delayed-release-mini-capsules-301555901.html

This article originally appeared on MPR